跳转至内容
Merck

SAB4200256

Sigma-Aldrich

Anti-AKT1S1 antibody, Mouse monoclonal

clone AKT1S1-3, purified from hybridoma cell culture

别名:

Monoclonal Anti-AKT1 substrate 1 (proline-rich), Monoclonal Anti-Lobe, Monoclonal Anti-PRAS40, Monoclonal Anti-PROLINE-RICH AKT SUBSTRATE, 40-KD

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
NACRES:
NA.44

生物源

mouse

共軛

unconjugated

抗體表格

purified from hybridoma cell culture

抗體產品種類

primary antibodies

無性繁殖

AKT1S1-3, monoclonal

形狀

buffered aqueous solution

分子量

antigen ~40 kDa

物種活性

human

濃度

~1.0 mg/mL

技術

immunoprecipitation (IP): suitable
western blot: 2-8 μg/mL using whole extracts of human MDA-MB-231cells.

同型

IgG1

UniProt登錄號

運輸包裝

dry ice

儲存溫度

−20°C

目標翻譯後修改

unmodified

基因資訊

human ... AKT1S1(84335)

一般說明

AKT1S1 is a raptor-associated protein that interacts with mTORC1 and subsequently inhibits the mTORC1 signaling pathway. This raptor-binding protein also inhibits phosphorylation of S6K1 and cell growth. Expression of AKT1S1 has been implicated in breast and pulmonary carcinogenesis, as well as in mediating insulin sensitivity . Monoclonal Anti-AKT1S1 antibody is specific for human AKT1S1 (approx. 40 kDa).
Monoclonal Anti-AKT1S1 (mouse IgG1 isotype) is derived from the hybridoma AKT1S1-3 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a fusion protein corresponding to the N-terminus of human AKT1S1. Akt1 substrate 1 (AKT1S1) is also named as proline-rich Akt-substrate of 40 kDa (PRAS40). The rapamycin-sensitive mammalian target of rapamycin complex 1 (mTORC1) consists of mTOR, raptor, mLST8 and AKT1S1, that controls protein translation. AKT1S1 contains a TOR signaling (TOS) motif that mediates its binding to mTORC1.

免疫原

The corresponding sequence differs by a single amino acid in rat, and by 2 amino acids in mouse AKT1S1.
fusion protein corresponding to the N-terminus of human AKT1S1.

應用

Monoclonal Anti-AKT1S1 antibody is suitable for use in western blot (2-8 μg/mL using whole extracts of human MDA-MB-231cells) and immunoprecipitation.

生化/生理作用

Akt1 substrate 1 (AKT1S1) is involved in the PI3KAkt/ protein kinase B (PKB) survival pathway. Phosphorylation of AKT1S1 by Akt and mammalian target of rapamycin complex 1 (mTORC1) disrupts the binding between mTORC1 and AKT1S1, relieves the inhibitory effect of AKT1S1 on mTORC1 activity, and leads to the binding of AKT1S1 to 14-3-3, a cytosolic anchor protein. The binding of AKT1S1 to 14-3-3 requires amino acids and insulin, which is partially inhibited by rapamycin.

外觀

0.01M 磷酸缓冲盐溶液,pH 7.4,含 15mM 叠氮化钠。

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
Wang L, et al.
Test, 282(27), 20036-20044 (2007)
PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex
Fonseca BD, et al.
Test, 282(34), 24514-24524 (2007)
Role of PRAS40 in Akt and mTOR signaling in health and disease
Wiza C, et al.
American Journal of Physiology. Endocrinology and Metabolism, 302(12), E1453-E1460 (2012)
Bei Huang et al.
Acta pharmacologica Sinica, 26(10), 1253-1258 (2005-09-22)
To study the expression of proline-rich Akt-substrate PRAS40 in the cell survival pathway and tumor progression. The effects of three key kinase inhibitors on PRAS40 activity in the cell survival pathway, serum withdrawal, H(2)O(2) and overexpression of Akt were tested.
Emilie Vander Haar et al.
Nature cell biology, 9(3), 316-323 (2007-02-06)
Insulin stimulates protein synthesis and cell growth by activation of the protein kinases Akt (also known as protein kinase B, PKB) and mammalian target of rapamycin (mTOR). It was reported that Akt activates mTOR by phosphorylation and inhibition of tuberous

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门